UPPSALA UNIVERSITET - (Coördinator)
Country:
Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966
Full project pageOrganisations map overview
ACTELION PHARMACEUTICALS LTD
Country:
AMGEN LIMITED
Country:
ASTELLAS PHARMA EUROPE BV
Country:
ASTRAZENECA AB
Country:
AbbVie Ltd
Country:
BAYER AKTIENGESELLSCHAFT (BAYER)
Country:
Bayer Pharma AG
Country:
CSL BEHRING GMBH
Country:
ELI LILLY AND COMPANY LTD
Country:
ERASMUS UNIVERSITEIT ROTTERDAM
Country:
EUROPEAN CANCER PATIENT COALITION
Country:
F. HOFFMANN-LA ROCHE AG
Country:
FORUM DES PATIENTS EUROPEENS
Country:
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Country:
JANSSEN PHARMACEUTICA NV
Country:
KATHOLIEKE UNIVERSITEIT LEUVEN
Country:
MERCK KGAA
Country:
MERCK SHARP & DOHME CORP
Country:
MINDBYTES
Country:
NOVARTIS PHARMA AG
Country:
PFIZER LIMITED
Country:
TAKEDA DEVELOPMENT CENTRE EUROPE LTD
Country:
THE UNIVERSITY OF BIRMINGHAM
Country:
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Country:
UNIVERSITATSKLINIKUM ERLANGEN
Country:
UNIVERSITY OF NEWCASTLE UPON TYNE
Country: